Profil
Weng Tao is the founder of Neurotech Pharmaceuticals, Inc. which was founded in 1995.
She held the titles of CSO and VP-Research & Development from 2011 to 2013.
Dr. Tao also worked as a Director-Cell Research at CytoTherapuetics, Inc. and as a Principal at Regeneron Pharmaceuticals, Inc. Dr. Tao holds a doctorate degree from both the University of Connecticut and Capital Medical University.
Ehemalige bekannte Positionen von Weng Tao
| Unternehmen | Position | Ende |
|---|---|---|
CytoTherapuetics, Inc.
CytoTherapuetics, Inc. Financial ConglomeratesFinance Biological Products | Corporate Officer/Principal | - |
| REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Neurotech Pharmaceuticals, Inc. (United States)
Neurotech Pharmaceuticals, Inc. (United States) Pharmaceuticals: MajorHealth Technology Designs and develops therapeutic systems for retinal diseases | Gründer | - |
Ausbildung von Weng Tao
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and commercializes medicines for diseases | Health Technology |
Neurotech Pharmaceuticals, Inc. (United States)
Neurotech Pharmaceuticals, Inc. (United States) Pharmaceuticals: MajorHealth Technology Designs and develops therapeutic systems for retinal diseases | Health Technology |
CytoTherapuetics, Inc.
CytoTherapuetics, Inc. Financial ConglomeratesFinance Biological Products | Finance |
University of Connecticut
University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Capital Medical University
Capital Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















